Norway· NO-ID_8170FA56-53A4-42BA-9E12-C4447C3FFC1A
Lyovac-Cosmegen
A dactinomycin product containing dactinomycin, registered in Norway by Orphan Europe. The same ATC class is registered in 7 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Dactinomycin is registered in 7 of 19 countries.
Countries holding a registration under ATC L01DA01 (dactinomycin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 4 of them publish a price we can compare per daily dose
Dactinomycin · ATC L01DA01
7 / 19 countries
- Canada
- Finlandprice
- Franceprice
- Germany
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Dactinomycin
- Manufacturer
- Orphan Europe
- Country
- Norway (NO)
- ATC code
- L01DA01
- ATC class
- Dactinomycin
- Defined daily dose
- 0.32 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 2
- no_merkevare_idID_8170FA56-53A4-42BA-9E12-C4447C3FFC1A
- no_varenummer2386580.5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
163 interactions on record for dactinomycin.
Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dactinomycin · interactions on record
163 records
- 30 severe
- 83 moderate
- 15 minor
- 35 info
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dactinomycin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCosmegen Lyovac 500microgram powder for solution for injection vialsRecordati Rare Diseases UK Ltd
- United StatesdactinomycinXGen Pharmaceuticals DJB, Inc.
- GermanyLyovac-CosmegenRecordati Rare Diseases
- FinlandCosmegenLundbeck Pharmaceuticals Ireland Limited
- CanadaCOSMEGENRECORDATI RARE DISEASES CANADA INC
- JapanアクチノマイシンＤノーベルファーマ
- FranceCOSMEGEN 0,5 mg, poudre pour solution injectableRECORDATI RARE DISEASES
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Germany · Lyovac-Cosmegen
- France · Cosmegen
- Italy · Cosmegen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/07dca01a-a4ac-422c-a2af-d53281873ad7 GET /v1/drugs/07dca01a-a4ac-422c-a2af-d53281873ad7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Daktinomycin",
"merkevare_id": "ID_8170FA56-53A4-42BA-9E12-C4447C3FFC1A",
"name_form_strength": "Lyovac-Cosmegen pulv til inj væske, oppl 0,5 mg",
"prescription_group": "C"
}See everything about dactinomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.